Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony S Basile

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Life Sciences|November 11, 2003
Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technologyMasahisa Yamada, Anthony S Basile, Irina Fedorova, et al.
Pharmacology, Biochemistry, and Behavior|August 14, 2012
Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatologyKaitlin T Warnock, Andrew R S T Yang, Heon S Yi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 25, 2004
A pulmonary formulation of L-dopa enhances its effectiveness in a rat model of Parkinson's diseaseRaymond T Bartus, Dwaine Emerich, Pam Snodgrass-Belt, et al.
Molecular Pharmacology|October 23, 2002
Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout miceAlokesh Duttaroy, Jesus Gomeza, Jai-Wei Gan, et al.
Molecular Pharmaceutics|December 28, 2012
Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructuresAmber Dahlin, Ethan Geier, Sophie L Stocker, et al.
Alcoholism, Clinical and Experimental Research|December 14, 2011
Effects of the triple monoamine uptake inhibitor DOV 102,677 on alcohol-motivated responding and antidepressant activity in alcohol-preferring (P) ratsAndrew R S T Yang, Heon S Yi, Kaitlin T Warnock, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2006
The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptorsPiotr Popik, Emmanuel Kostakis, Martyna Krawczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2007
Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic painAnthony S Basile, Aaron Janowsky, Krystyna Golembiowska, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2007
The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesityJoseph P Tizzano, D Sloan Stribling, Diego Perez-Tilve, et al.
Investigative Ophthalmology & Visual Science|October 18, 2012
Dose-ranging evaluation of intravitreal siRNA PF-04523655 for diabetic macular edema (the DEGAS study)Quan Dong Nguyen, Ronald A Schachar, Chudy I Nduaka, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Life Sciences|November 11, 2003
Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technologyMasahisa Yamada, Anthony S Basile, Irina Fedorova, et al.
Pharmacology, Biochemistry, and Behavior|August 14, 2012
Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatologyKaitlin T Warnock, Andrew R S T Yang, Heon S Yi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 25, 2004
A pulmonary formulation of L-dopa enhances its effectiveness in a rat model of Parkinson's diseaseRaymond T Bartus, Dwaine Emerich, Pam Snodgrass-Belt, et al.
Molecular Pharmacology|October 23, 2002
Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout miceAlokesh Duttaroy, Jesus Gomeza, Jai-Wei Gan, et al.
Molecular Pharmaceutics|December 28, 2012
Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructuresAmber Dahlin, Ethan Geier, Sophie L Stocker, et al.
Alcoholism, Clinical and Experimental Research|December 14, 2011
Effects of the triple monoamine uptake inhibitor DOV 102,677 on alcohol-motivated responding and antidepressant activity in alcohol-preferring (P) ratsAndrew R S T Yang, Heon S Yi, Kaitlin T Warnock, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2006
The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptorsPiotr Popik, Emmanuel Kostakis, Martyna Krawczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2007
Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic painAnthony S Basile, Aaron Janowsky, Krystyna Golembiowska, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2007
The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesityJoseph P Tizzano, D Sloan Stribling, Diego Perez-Tilve, et al.
Investigative Ophthalmology & Visual Science|October 18, 2012
Dose-ranging evaluation of intravitreal siRNA PF-04523655 for diabetic macular edema (the DEGAS study)Quan Dong Nguyen, Ronald A Schachar, Chudy I Nduaka, et al.
Pageof 4